Figure 3.

combination drug simulation result on T2D model. Combination drug (Metformin and rosiglitazone) effect pathway on T2D model.

Hwang et al. BMC Medical Informatics and Decision Making 2013 13(Suppl 1):S4   doi:10.1186/1472-6947-13-S1-S4